Fig. 6From: Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkersCorrelation between FGF21 and liver steatosis measured by controlled attention parameter (CAP)Back to article page